Litigation Details for Bristol-Myers Squibb Company v. InvaGen Pharmaceuticals, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Bristol-Myers Squibb Company v. InvaGen Pharmaceuticals, Inc. (D. Del. 2017)
| Docket | ⤷ Subscribe | Date Filed | 2017-04-05 |
| Court | District Court, D. Delaware | Date Terminated | 2018-09-24 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Patents | 9,326,945 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Bristol-Myers Squibb Company v. InvaGen Pharmaceuticals, Inc.
The small molecule drug covered by the patent cited in this case is ⤷ Subscribe .
Details for Bristol-Myers Squibb Company v. InvaGen Pharmaceuticals, Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-04-05 | 1 | prior to expiration of U.S. Patent No. 9,326,945 (the “’945 patent” or “patent-in-suit”). …. This is an action for patent infringement arising under the patent laws of the United States, … PATENT-IN-SUIT 13. On May 3, 2016, the U.S. Patent and Trademark Office…the ’945 patent, titled “Apixaban Formulations.” A true and correct copy of the ’945 patent is attached… COMPLAINT FOR PATENT INFRINGEMENT filed against InvaGen Pharmaceuticals, Inc. - Magistrate Consent | External link to document | |
| 2017-04-05 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,326,945 B2. (crb) (Entered… 24 September 2018 1:17-cv-00377 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
